FDC
Quarterly Results Analysis [Dec2024]
FDC Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹464 Cr | ₹514 Cr | ₹638 Cr | ₹462 Cr | ₹458 Cr | ₹486 Cr | ₹536 Cr | ₹435 Cr |
Expenses | ₹417 Cr | ₹444 Cr | ₹492 Cr | ₹406 Cr | ₹374 Cr | ₹410 Cr | ₹414 Cr | ₹386 Cr |
Operating Income | ₹47 Cr | ₹70 Cr | ₹147 Cr | ₹56 Cr | ₹84 Cr | ₹76 Cr | ₹122 Cr | ₹49 Cr |
Other Income | ₹19 Cr | ₹35 Cr | ₹28 Cr | ₹20 Cr | ₹25 Cr | ₹27 Cr | ₹29 Cr | ₹7 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹13 Cr | ₹14 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Profit Before Tax | ₹51 Cr | ₹90 Cr | ₹163 Cr | ₹65 Cr | ₹98 Cr | ₹93 Cr | ₹141 Cr | ₹45 Cr |
Profit After Tax | ₹37 Cr | ₹72 Cr | ₹119 Cr | ₹46 Cr | ₹79 Cr | ₹70 Cr | ₹110 Cr | ₹31 Cr |
EPS | ₹2.28 | ₹4.42 | ₹7.31 | ₹2.84 | ₹4.87 | ₹4.29 | ₹6.62 | ₹1.85 |
Industry Peers & Returns | 1W | 1M | 1Y |
FDC | -3.5% | 2.8% | -6% |
SUN PHARMACEUTICAL INDUSTRIES | 0.9% | 2.2% | 23.9% |
DIVIS LABORATORIES | 3.3% | 4.7% | 58% |
CIPLA | 0.5% | 2% | 11.1% |
TORRENT PHARMACEUTICALS | -0.4% | 2.8% | 24.2% |
DR REDDYS LABORATORIES | -0.8% | -0.4% | 0.8% |
MANKIND PHARMA | 0.5% | 6.6% | 6.6% |
ZYDUS LIFESCIENCES | 2.3% | -2.2% | -5.1% |
LUPIN | -1% | -0.1% | 33.4% |
FDC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -9.68 % |
Y-o-Y | 1.30 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹464 Cr | -9.68 | |
Sep2024 | ₹514 Cr | -19.49 | |
Jun2024 | ₹638 Cr | 38.14 | |
Mar2024 | ₹462 Cr | 0.84 | |
Dec2023 | ₹458 Cr | -5.80 | |
Sep2023 | ₹486 Cr | -9.32 | |
Jun2023 | ₹536 Cr | 23.36 | |
Mar2023 | ₹435 Cr | - |
FDC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -33.51 % |
Y-o-Y | -44.32 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹47 Cr | -33.51 | |
Sep2024 | ₹70 Cr | -52.15 | |
Jun2024 | ₹147 Cr | 160.31 | |
Mar2024 | ₹56 Cr | -32.78 | |
Dec2023 | ₹84 Cr | 9.64 | |
Sep2023 | ₹76 Cr | -37.36 | |
Jun2023 | ₹122 Cr | 149.22 | |
Mar2023 | ₹49 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -26.37 % |
Y-o-Y | -45.05 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 10.05% | -26.37 | |
Sep2024 | 13.65% | -40.57 | |
Jun2024 | 22.97% | 88.43 | |
Mar2024 | 12.19% | -33.35 | |
Dec2023 | 18.29% | 16.42 | |
Sep2023 | 15.71% | -30.95 | |
Jun2023 | 22.75% | 102.04 | |
Mar2023 | 11.26% | - |
FDC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -48.58 % |
Y-o-Y | -53.22 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹37 Cr | -48.58 | |
Sep2024 | ₹72 Cr | -39.48 | |
Jun2024 | ₹119 Cr | 157.20 | |
Mar2024 | ₹46 Cr | -41.54 | |
Dec2023 | ₹79 Cr | 13.45 | |
Sep2023 | ₹70 Cr | -36.45 | |
Jun2023 | ₹110 Cr | 258.14 | |
Mar2023 | ₹31 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -43.08 % |
Y-o-Y | -53.82 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 7.98 % | -43.08 | |
Sep2024 | 14.02 % | -24.83 | |
Jun2024 | 18.65 % | 86.13 | |
Mar2024 | 10.02 % | -42.01 | |
Dec2023 | 17.28 % | 20.42 | |
Sep2023 | 14.35 % | -29.90 | |
Jun2023 | 20.47 % | 190.35 | |
Mar2023 | 7.05 % | - |
FDC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -48.42 % |
Y-o-Y | -53.18 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹2.28 | -48.42 | |
Sep2024 | ₹4.42 | -39.53 | |
Jun2024 | ₹7.31 | 157.39 | |
Mar2024 | ₹2.84 | -41.68 | |
Dec2023 | ₹4.87 | 13.52 | |
Sep2023 | ₹4.29 | -35.20 | |
Jun2023 | ₹6.62 | 257.84 | |
Mar2023 | ₹1.85 | - |
You may also like the below Video Courses